Alterations of biologic properties and gene expression in nasopharyngeal epithelial cells by the Epstein-Barr virus-encoded latent membrane protein 1

Laboratory Investigation

Volumn 83, Issue 5, 2003, Pages 697-709

  Lo, Angela Kwok Fung ^a   Liu, Yu ^a   Wang, Xiang Hong ^a   Huang, Dolly P ^b   Yuen, Po Wing ^a   Wong, Yong Chuan ^a   Tsao, George Sai Wah ^a,c  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

LATENT MEMBRANE PROTEIN 1;

ANCHORAGE INDEPENDENT GROWTH; ARTICLE; CELL DEATH; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL SHAPE; CELL TRANSFORMATION; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENE; GENE CONTROL; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; ITGALPHA6 GENE; LAMC2 GENE; NASOPHARYNX CARCINOMA; PATHOGENESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VECTOR CONTROL;

EID: 0038814052     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.LAB.0000067480.44925.10     Document Type: Article

References (43)

1. Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM, and McEwan RN (1987). A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 47:3239-3245.
2. Artavanis-Tsakonas S, Rand MD, and Lake RJ (1999). Notch signaling: Cell fate control and signal integration in development. Science 284:770-776.
3. Birkenbach M, Liebowitz D, Wang F, Sample J, and Kieff E (1989). Epstein-Barr virus latent infection membrane protein increases vimentin expression in human B-cell lines. J Virol 63:4079-4084.
4. Danen EH and Yamada KM (2001). Fibronectin, integrins, and growth control. J Cell Physiol 189:1-13.
5. Dawson CW, Rickinson AB, and Young LS (1990). Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiation. Nature 344:777-780.
6. Eliopoulos AG, Gallagher NJ, Blake SM, Dawson CW, and Young LS (1999). Activation of the p38 mitogen-activated protein kinase pathway by Epstein-Barr virus-encoded latent membrane protein 1 coregulates interleukin-6 and interleukin-8 production. J Biol Chem 274:16085-16096.
7. Fahraeus R, Chen W, Trivedi P, Klein G, and Obrink B (1992). Decreased expression of E-cadherin and increased invasive capacity in EBV-LMP-transfected human epithelial and murine adenocarcinoma cells. Int J Cancer 52:834-838.
8. Fahraeus R, Fu HL, Ernberg I, Finke J, Rowe M, Klein G, Falk K, Nilsson E, Yadav M, and Busson P (1988). Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma. Int J Cancer 42:329-338.
9. Fahraeus R, Rymo L, Rhim JS, and Klein G (1990). Morphological transformation of human keratinocytes expressing the LMP gene of Epstein-Barr virus. Nature 345:447-449.
10. Goruppi S, Ruaro E, Varnum B, and Schneider C (1999). Gas6-mediated survival in NIH3T3 cells activates stress signalling cascade and is independent of Ras. Oncogene 18:4224-4236.
11. Horikawa T, Yoshizaki T, Sheen TS, Lee SY, and Furukawa M (2000). Association of latent membrane protein 1 and matrix metalloproteinase 9 with metastasis in nasopharyngeal carcinoma. Cancer 89:715-723.
12. Hu LF, Chen F, Zhen QF, Zhang YW, Luo Y, Zheng X, Winberg G, Ernberg I, and Klein G (1995). Differences in the growth pattern and clinical course of EBV-LMP1 expressing and non-expressing nasopharyngeal carcinomas. Eur J Cancer 31A:658-660.
13. Hu LF, Chen F, Zheng X, Ernberg I, Cao SL, Christensson B, Klein G, and Winberg G (1993). Clonability and tumorigenicity of human epithelial cells expressing the EBV encoded membrane protein LMP1. Oncogene 8:1575-1583.
14. Huang DP, Ho JH, Poon YF, Chew EC, Saw D, Liu MC, Li CL, Mak JM, Lai SH, and Lau WH (1980). Establishment of a cell line (NPC/HK1) from a differentiated squamous carcinoma of nasopharynx. Int J Cancer 26:127-132.
15. Jarasch ED, Nagle RB, Kaufmann M, Maurer C, and Bocker WJ (1988). Differential diagnosis of benign epithelial proliferations and carcinomas of the breast using antibodies to cytokeratins. Hum Pathol 19:276-289.
16. Kang T, Yi J, Yang W, Wang X, Jiang A, and Pei D (2000). Functional characterization of MT3-MMP in transfected MDCK cells: Progelatinase A activation and tubulogenesis in 3-D collagen lattice. FASEB J 14:2559-2568.
17. Kawanishi M (1997). Expression of Epstein-Barr virus latent membrane protein 1 protects Jurkat T cells from apoptosis induced by serum deprivation. Virology 228:244-250.
18. Kim KR, Yoshizaki T, Miyamori H, Hasegawa K, Horikawa T, Furukawa M, Harada S, Seiki M, and Sato H (2000). Transformation of Madin-Darby canine kidney (MDCK) epithelial cells by Epstein-Barr virus latent membrane protein 1 (LMP1) induces expression of Ets1 and invasive growth. Oncogene 19:1764-1771.
19. Kitagawa Y, Kunimi K, Uchibayashi T, Sato H, and Namiki M (1999). Expression of messenger RNAs for membrane-type 1, 2, and 3 matrix metalloproteinases in human renal cell carcinomas. J Urol 162:905-909.
20. Lo AKF, Liu Y, Wang X, Wong YC, Lee CK, Huang DP, and Tsao SW (2001a). Identification of downstream target genes of latent membrane protein 1 in nasopharyngeal carcinoma cells by suppression subtractive hybridization. Biochim Biophys Acta 1520:131-140.
21. Lo AKF, Yuen PW, Liu Y, Wang XH, Cheung ALM, Wong YC, and Tsao SW (2001b). Downregulation of hemidesmosomal proteins in nasopharyngeal carcinoma cells. Cancer Lett 163:117-124.
22. Mark MR, Chen J, Hammonds RG, Sadick M, and Godowsk PJ (1996). Characterization of Gas6, a member of the superfamily of G domain-containing proteins, as a ligand for Rse and Axl. J Biol Chem 271:9785-9789.
23. Miettinen PJ, Ebner R, Lopez AR, and Derynck R (1994). TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: Involvement of type I receptors. J Cell Biol 127:2021-2036.
24. Miller WE, Cheshire JL, Baldwin AS Jr, and Raab-Traub N (1998). The NPC derived C15 LMP1 protein confers enhanced activation of NF-kappa B and induction of the EGFR in epithelial cells. Oncogene 16:1869-1877.
25. Murono S, Inoue H, Tanabe T, Joab I, Yoshizaki T, Furukawa M, and Pagano JS (2001). Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells. Proc Natl Acad Sci USA 98:6905-6910.
26. Pathmanathan R, Prasad U, Sadler R, Flynn K, and Raab-Traub N (1995). Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N Engl J Med 333:693-698.
27. Pollack V, Scheiber K, Pfaller W, and Schramek H (1997). Loss of cytokeratin expression and formation of actin stress fibers in dedifferentiated MDCK-C7 cell lines. Biochem Biophys Res Commun 241:541-547.
28. Portella G, Cumming SA, Liddell J, Cui W, Ireland H, Akhurst RJ, and Balmain A (1998). Transforming growth factor beta is essential for spindle cell conversion of mouse skin carcinoma in vivo: Implications for tumor invasion. Cell Growth Differ 9:393-404.
29. Rangarajan A, Talora C, Okuyama R, Nicolas M, Mammucari C, Oh H, Aster JC, Krishna S, Metzger D, Chambon P, Miele L, Aguet M, Radtke F, and Dotto GP (2001). Notch signaling is a direct determinant of keratinocyte growth arrest and entry into differentiation. EMBO J 20:3427-3436.
30. Rickinson AB and Kieff E (1996). Epstein-Barr virus. In: Fields BN, Knipe DM, and Howley PM, editors. Fields virology. Philadelphia: Lippincott-Raven, 2397-2446.
31. Roberts ML and Cooper NR (1998). Activation of a ras-MAPK-dependent pathway by Epstein-Barr virus latent membrane protein 1 is essential for cellular transformation. Virology 240:93-99.
32. Ruiz-Hidalgo MJ, Garces C, and Laborda J (1999). Notch-1 expression levels in 3T3-L1 cells influence ras signaling and transformation by oncogenic ras. Int J Oncol 14:777-783.
33. Sham JS, Choy D, and Wei WI (1990). Nasopharyngeal carcinoma: Orderly neck node spread. Int J Radiat Oncol Biol Phys 19:929-933.
34. Stammberger P and Baczako K (1999). Cytokeratin 19 expression in human gastrointestinal mucosa during human prenatal development and in gastrointestinal tumours: Relation to cell proliferation. Cell Tissue Res 298:377-381.
35. Takino T, Sato H, Shinagawa A, and Seiki M (1995). Identification of the second membrane-type matrix metalloproteinase (MT-MMP-2) gene from a human placenta cDNA library: MT-MMPs form a unique membrane-type subclass in the MMP family. J Biol Chem 270:23013-23020.
36. Teng ZP, Ooka T, Huang DP, and Zeng Y (1996). Detection of Epstein-Barr virus DNA in well and poorly differentiated nasopharyngeal carcinoma cell lines. Virus Genes 13:53-60.
37. Tsao SW, Wong X, Liu Y, Cheung ALM, Feng H, Zheng Z, Wong N, Yuen PW, Lo AKF, Wong YC, and Huang DP (2002). Establishment of two immortalized nasopharyngeal epithelial cell lines using SV40 large T and HPV16E6/E7 viral oncogenes. Biochim Biophys Acta 1590:150-158.
38. van der Velden LA, Schaafsma HE, Manni JJ, Ramaekers FC, and Kuijpers W (1993). Cytokeratin expression in normal and (pre)malignant head and neck epithelia: An overview. Head Neck 15:133-146.
39. Wilson JB, Weinberg W, Johnson R, Yuspa S, and Levine AJ (1990). Expression of the BNLF-1 oncogene of Epstein-Barr virus in the skin of transgenic mice induces hyperplasia and aberrant expression of keratin 6. Cell 61:1315-1327.
40. Winer J, Jung CK, Shackel I, and Williams PM (1999). Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal Biochem 270:41-49.
41. Yang X, Sham JS, Ng MH, Tsao SW, Zhang D, Lowe SW, and Cao L (2000). LMP1 of Epstein-Barr virus induces proliferation of primary mouse embryonic fibroblasts and cooperatively transforms the cells with a p16-insensitive CDK4 oncogene. J Virol 74:883-891.
42. Yoshizaki T, Sato H, Furukawa M, and Pagano JS (1998). The expression of matrix metalloproteinase 9 is enhanced by Epstein-Barr virus latent membrane protein 1. Proc Natl Acad Sci USA 95:3621-3626.
43. Yu Y and Sato JD (1999). MAP kinases, phosphatidylinositol 3-kinase, and p70 S6 kinase mediate the mitogenic response of human endothelial cells to vascular endothelial growth factor. J Cell Physiol 178:235-246.